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Moutan Cortex in LPS-Activated Raw264.7 Cells
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Sang Chan Kim
College of Oriental Medicine and Research Center for Biomedical Resources of Oriental Medicine, Daegu Haany
University, Daegu 706-828, Republic of Korea
Moutan Cortex (MCE) has been used in traditional medicine to remove heat from the blood, promote
blood circulation and alleviate blood stasis. This study was conducted to evaluate the effects of MCE on
regulatory mechanisms of cytokines and nitric oxide (NO) involved in immunological activity of
Raw264.7 cells. Cells were pretreated with methanolic extracts of MCE, and further cultured for an
appropriate time after lipopolyssacharide (LPS) addition. During the entire experimental period, 0.1 and
0.3 mg ml
 1 of MCE had no cytotoxicity. In these concentrations, MCE inhibited the production of NO
and prostaglandin E2 (PGE2), the expression of inducible NO synthase (iNOS), cyclooxygenase-
2 (COX-2) and phosphorylated inhibitor of kBa (p-IkBa), and the activation of nuclear factor kB (NF-
kB). MCE also reduced the concentration of tumor necrosis factor-a (TNF-a), interleukin-1b (IL-1b)
and interleukin-6 (IL-6) in the Raw264.7 cells that were activated by LPS. These results demonstrate
that MCE has anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by
suppressing the phosphorylation of I-kBa and the activation of NF-kB.
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Introduction
Moutan Cortex (MCE), the root cortex of Paeonia suffruticosa
Andrews, is a traditional Korean herb with various biological
activities. It has been used in oriental medicine to remove
heat from the blood, promote blood circulation and remove
blood stasis (1). Moutan Cortex has been shown to have
antimicrobial actions against Escherichia coli, typhoid, para-
typhoid bacilli and Cholera vibrio, and antihypertensive
efficacy including analgesic, sedative and anticonvulsant
effects. Moutan Cortex exerts a protective effect against
acetaminophen-induced hepatotoxicity by attenuating GSH
depletion, cytochrome P450 2E1 activity and hepatic DNA
damage (2,3), and scavenging effects on the DPPH (1,1-
diphenyl-2-picrylhydrazyl) radical, superoxide anion radical
(4), hydroxy radicals (5) and intracellular ROS in oxidative
condition (6).
Lipopolyssacharide (LPS)-activated macrophages have
usually been used for evaluating the anti-inflammatory effects
of various materials. LPS is a principle component of the outer
membrane of Gram-negative bacteria, is an endotoxin that
induces septic shock syndrome and stimulates the production
of inflammatory mediators such as nitric oxide (NO), tumor
necrosis factor-a (TNF-a), interleukins, prostanoids and
leukotrienes (7–9). Therefore, LPS plays a key role in not
only eliciting an inflammatory response but also causing septic
shock during a Gram-negative bacterial infection. Inflammat-
ory responses are advantageous for eradicating bacteria, as
long as they are under control. However, when out of control,
deregulated inflammation leads to the massive production
of proinflammatory cytokines such as TNF-a, interleukin-1
(IL-1) and interleukin-6 (IL-6) by macrophages (10,11), which
can cause tissue injury and multiple organ failure (12).
Recently, there have been many studies concerning natural
products with anti-inflammatory activity, for example, Poly-
gonum tinctorium (13), Melia azedarach (14), Cyperus
rotundus (15,16), Cudrania tricuspidata (17), Ginsenoside
Rg3 (18), sauchinone (19,20), curcuma rhizomes (21) and
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as an anti-inflammatory agent in oriental medicine, the
mechanisms of anti-iflammatory activity of Moutan Cortex
have not been studied scientifically. Paeonol is a major
component of Moutan Cortex that may be largely responsible
for the therapeutic effect of Moutan Cortex. Paeonol regulated
histamine, IgE and TNF-a (23). However, it is not enough
to explain the anti-inflammatory activity of paeonol
and Moutan Cortex. There is no evidence to explain the
mechanism on the inflammatory cytokine regulation of
Moutan Cortex. Including paeonol, there are many known
chemical components of Moutan Cortex such as paenoside,
paeonolide, paeoniflorin, oxypaeonolniflorin, benzoylpaeoni-
florin, benzoyl-oxy-paeoniflorin and apiopaeonoside. There-
fore, this study evaluated the effect of methanol extract of
Moutan Cortex (MCE) on the regulatory mechanism of NO,
cytokines and prostaglandin E2 (PGE2) in the LPS-activated
Raw264.7 cells.
Methods
Preparation of Methanol Extract of Moutan Cortex
Moutan Cortex (300 g, Wolsung, Daegu, Korea) was extracted
with 1000 ml of methanol at room temperature for 24 h. The
extract was filtered through a 0.2 mm filter (Nalgene, New
York, NY, USA), lyophilized and stored at  20 C until
needed. The amount of the extract was estimated by dividing
the dried weight of Moutan Cortex into the lyophilized MCE.
The yield of MCE from Moutan Cortex was 13.2%.
Cell Culture
Raw264.7 cell, which is a murine macrophage cell line
(KCLRF, Korean Cell Line Research Foundation, Seoul,
Korea), was cultured in Dulbecco’s modified Eagle’s medium
(DMEM, Cambrex Bio Science, MD, USA) containing 10%
fetal bovine serum (FBS), 100 U ml
 1 penicillin and 100 mg
ml
 1 streptomycin. For all experiments, the cells were grown
to 80–90% confluence, and were subjected to no more than
20 cell passages. The cells were maintained at 37 Ci na
humidified atmosphere containing 5% CO2. The Raw264.7
cells were plated at a density of 2–3 · 10
6 per ml and
preincubated at 37 C for 24 h. After serum starvation for 12 h,
the cells were exposed to either LPS (1 mgm l
 1) or LPS þ
MCE for the indicated time periods (6–24 h). MCE was
dissolved in a medium (EMEM, Cambrex Bio Science, MD,
USA) and added to the incubation medium 1 h prior to adding
the LPS.
Reagents
LPS (E. coli 026:B6) and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoleum (MTT) were obtained from Sigma
(St Louis, MO, USA). The FBS and antibiotics were purchased
from Gibco/BRL (Eggenstein, Germany). The antibodies
were obtained from BD Bioscience (USA), Cayman (USA)
and Zymed (USA), and the NC paper used was Schleicher
& Schuell (USA). The TNF-a, IL-6 and interleukin-1b (IL-1b)
ELISA kits were purchased from Pierce endogen (Rockford,
IL, USA).
Assay of NO Production
The level of NO production was monitored by measuring the
nitrite concentration in the cultured medium. Briefly, the
samples were mixed with Griess reagent (1% sulfanilamide,
0.1% N-1-naphthylenediamine dihydrochloride and 2.5%
phosphoric acid) and incubated for 10 min at room tempera-
ture. The absorbance was measured at 540 nm using a Titertek
Multiskan Automatic ELISA microplate reader (Model MCC/
340, Huntsville, AL).
Cell Viability (MTT assay)
The Raw264.7 cells were plated at a density of 5· 10
4 cells per
well in a 96-well plate to determine the cytotoxic concentra-
tions of MCE. The cells were exposed to MCE at concentra-
tions of 0.1 and 0.3 mg ml
 1 at 37 C under 5% CO2. After
incubating the cells in the presence of MCE, the viable cells
were stained with MTT (0.5 mg ml
 1) for 4 h. The media were
then removed and the formazan crystals produced in the wells
were dissolved in 200 ml of dimethylsulfoxide (DMSO). The
absorbance was measured at 540 nm using a Titertek
Multiskan Automatic ELISA microplate reader (Model
MCC/340, Huntsville, AL). The cell viability was defined as
the % of untreated control cells [i.e. viability (% control) ¼
100 · {(absorbance of MCE-treated sample)/(absorbance of
control)}].
Immunoblot Analysis
The cells were lysed in the buffer containing 20 mM Tris
(pH 7.5), 1% Triton X-100, 137 mM sodium chloride, 10%
glycerol, 2 mM EDTA, 1 mM sodium orthovanadate, 25 mM
beta-glycerophosphate, 2 mM sodium pyrophosphate, 1 mM
phenylmethylsulfonylfluoride and 1 mg ml
 1 leupeptin. The
total cell lysate was prepared by centrifuging the cells at
10000· g for 10 min and collecting the supernatant. The
expression of iNOS, cyclooxygenase-2 (COX-2) and phos-
phorylated inhibitor of kBa (p-IkBa) was immunochemically
monitored with the total lysate fraction using anti-mouse
iNOS, COX-2 and p-IkBa antibodies, respectively. The bands
for the iNOS, COX-2 and p-IkBa proteins were visualized
using ECL western blotting detection reagents (Amersham
Biosciences, NJ, USA) according to the manufacturer’s
instructions.
Gel Retardation Assay
A double-stranded DNA probe for the consensus sequence of
nuclear factor kB (NF-kB) (50-AGTTGAGGGGACTTTCCC-
AGGC-30) was used for the gel shift analyses after end labeling
the probes with [g-
32P]ATP and T4 polynucleotide kinase.
The reaction mixtures contained 2 mlo f5 · binding buffer
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2.5 mM dithiothreitol, 0.25 mg ml
 1 poly dI-dC and 50 mM
Tris–Cl, pH 7.5), 2 mg of the nuclear extracts and sterile water
in a total volume of 10 ml. The reactions were initiated by
adding 1 ml of the probe (10
6 c.p.m.) and preincubating the
resulting mixture for 10 min. Incubation was continued for
20 min at room temperature. The samples were loaded onto
4% polyacrylamide gels at 140 V. The gels were removed,
fixed and dried, followed by autoradiography.
Measurement of Cytokines Production
For the cytokine immunoassays, the cells (1 · 10
6 per ml) were
preincubated with MCE for 1 h and further cultured for 6 or
12 h with 1 mgm l
 1 of LPS in 6-well plates. The supernatants
were removed at the allotted times and the level of TNF-a,
IL-6 and IL-1b production was quantified using an ELISA
kit (Pierce endogen, Rockford, IL, USA) according to the
manufacturer’s instructions. Briefly, 50 ml of biotinylated
antibody reagent and the samples were added tothe anti-mouse
TNF-a, IL-6 and IL-1b precoated 96-well strip plates. The
plates were covered and kept at room temperature for 2 h and
washed three times in a prepared washing buffer. This was
followed by the addition of 100 ml of Streptavidin–HRP
concentrate. After 30 min incubation at room temperature, the
wells were washed three times, and 100 ml of TMB substrate
solution was then added and developed in the dark at room
temperature for 30 min. The reaction was quenched by adding
100 ml of TMB stop solution, and the absorbance of the plates
was at 450 nm to 550 nm using an automated microplate
ELISA reader. A standard curve was run on each assay plate
using recombinant TNF-a, IL-6 and IL-1b in serial dilutions.
Each kit was specific to TNF-a, IL-6 or IL-1b and does not
measure other cytokines.
Measurement of PGE2 Production
MCE was added to the culture medium 1 h before the addition
of 1 mgm l
 1 LPS. LPS-treated cells were further cultured with
vehicle or MCE for 24 h. The cultured medium was collected
and assayed with ELISA kit (RnD Systems, Minneapolis, MN,
USA). Cultured medium was incubated in goat anti-mouse IgG
coated plate with acetylcholinesterase linked to PGE2 and
PGE2 monoclonal antibody for 18 h at 4 C. The plate was
emptied and rinsed five times with wash buffer contained in
the kit. And then, 200 ml of substrate reagent was added to each
well and incubated for 1 h at 37 C. The developed plate was
read at 405 nm and the PGE2 concentration of each sample was
determined according to the standard curve.
Statistical Analysis
The data were expressed as a mean ± SD of the results obtained
from a number (n) of experiments. One-way analysis of
variance (ANOVA) was used to assess the significant
differences between the treatment groups. For each significant
effect of treatment, the Newman–Keuls test was used to
compare the multiple group means. A P-value <0.05 was
considered significant.
Results
MCE Inhibits LPS-Activated NO, Cytokines and
PGE2 Release
The inhibition of NO production by MCE was investigated by
measuring the level of NO production in Raw264.7 cells
treated with 0.1 and 0.3 mg ml
 1 of MCE. As shown in Fig. 1,
in the LPS plus MCE groups, the level of NO production
decreased in a concentration and time-dependent manner
compared with the LPS only group. In the 0.1 and 0.3 mg ml
 1
of MCE group, the level of NO was significantly inhibited at
12 h and 24 h (Fig. 1A).
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Figure 1. NO release and the cytotoxicity by MCE in LPS-activated
Raw264.7 cells. The NO concentration (A) in the culture medium and
cytotoxicity (B) were measured over a 6–24 h period. The data represent the
mean ± SD of eight separate experiments. One-way ANOVA was used to
compare the multiple group means followed by Newman–Keuls test
(*: significant compared with the control, **P < 0.01,
#: significant compared
with the LPS alone,
##P < 0.01).
eCAM 2007;4(3) 329Cell viability was measured at different MCE concentra-
tions for different times using an MTT assay in order to
determine if the decrease in NO production was caused by
a decrease in the cell population as a result of MCE-
induced cytotoxicity. The results showed that MCE con-
centration dose revealed no cytotoxicity over a 6 to 24 h
period (Fig. 1B).
We treated LPS toRaw264.7 cells, collected media every 3h
for 24 h, detected cytokines from the collected media, and then
determined appropriate time for each cytokine assay. TNF- a,
IL-1b and IL-6 were highly induced by LPS at 12, 12 and 6 h,
respectively (data are not shown). TNF-a,IL-1b and IL-6 from
the culture media were analyzed at the appropriate time. As
shown in Fig. 2, 0.3 mg ml
 1 of MCE significantly reduced the
level of TNF-a (Fig. 2A), IL-1b (Fig. 2B) and IL-6 (Fig. 2C) at
12, 12 and 6 h incubation. LPS-activated PGE2 also decreased
by MCE as compared to control (Fig. 2D). PGE2 per 1 ml
medium was 6.89 pg in control and increased to 48.6 pg in LPS
group. However, PGE2 was reduced to 30.2 and 14.5 pg ml
 1
in 0.1 and 0.3 mg ml
 1 of MCE, respectively.
Inhibitory Activities of MCE on LPS-Activated iNOS
and COX-2 Expression
The expression level of the iNOS protein in the cytosol
fraction was next examined using immunoblotting analysis.
The iNOS protein was strongly induced by LPS. The groups of
0.1 and 0.3 mg ml
 1 of MCE showed a decrease in iNOS
protein expression in a concentration-dependent manner. As
shown in Fig. 3, 0.3 mg ml
 1 of MCE with LPS strongly
suppressed the induction of iNOS.
COX-2 plays a key role in the development of inflammation
(24,25). MCE was further investigated to determine if it affects
the COX-2 expression levels. As shown in this experiment, the
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Figure 2. Inhibition of LPS-activated cytokines and PGE2 production by MCE. Raw264.7 cells were cultured with LPS (1 mgm l
 1) in the presence or absence of
MCE for 12 h to determine the level of TNF-a (A) and IL-1b (B). For IL-6 (C), the cells were incubatedfor 6 h under same conditions.For PGE2 (D), the cells were
incubated for 24 h under same conditions. The cultured medium was collected and directly assayed for cytokines and PGE2. Data represent the mean ± SD of eight
separate experiments. One-way ANOVA was used to compare the multiple group means followed by a Newman–Keuls test (*: significant as compared to control,
**P < 0.01,
#: significant as compared to LPS alone,
#P < 0.05,
##P < 0.01).
330 Anti-inflammatory effect of Moutan CortexCOX-2 protein was strongly induced by LPS. 0.1 mg ml
 1 of
MCE slightly suppressed the induction of COX-2, but 0.3 mg
ml
 1 of MCE with LPS strongly suppressed the induction of
COX-2 (Fig. 3).
Inhibitory Activities of MCE on IkBa Phosphorylation
and NF-kB Activation
In order to determine if MCE can directly affect p-IkBa
expression in macrophage cells, the level of p-IkBa protein
expression was assessed immunochemically in Raw264.7 cells
incubated with or without MCE. LPS increased the p-IkBa
level. However, 0.1 mg ml
 1 of MCE reduced the LPS-
inducible p-IkBa expression level, and 0.3 mg ml
 1 of MCE
markedly reduced the protein levels of p-IkBa expression in a
dose-dependent manner (Fig. 4A).
NF-kB is activated in cells challenged with LPS, and is
involved in the transcriptional activation of the responsive
genes. Gel shift analysis was carried out to determine if MCE
alters the NF-kB DNA binding activity. LPS (1 mgm l
 1,1h )
increased the binding activity of the nuclear extracts to the
NF-kB DNA consensus sequence. Although the treatment of
macrophages with 0.1 mg ml
 1 of MCE for 1 h prior to the
addition of LPS slightly inhibited the LPS-inducible increase
in the band intensity of NF-kB binding, a pretreatment with
0.3 mg ml
 1 of MCE significantly (<50%) suppressed the
band intensity that was increased by LPS (Fig. 4B).
Discussion
Inflammation is the first response of the immune system to
infection or irritation. It is caused by cytokines such as TNF-a,
IL-1 and IL-6 (10), and by eicosanoid such as PGE2 (26).
Thus, inhibitors of these cytokines have been considered as
a candidate of an anti-inflammatory drug. Moutan Cortex has
been used to diminish inflammation in oriental medicine.
However, few studies have been conducted to evaluate the
effects of Moutan Cortex on inflammation. Herbal medicine,
keishibukuryogan (Gui-Zhi-Fu-Ling-Wan) containing Moutan
Cortex, was reported to decrease disease activity evaluated by
levels of inflammatory cytokines (27). In this study, we show
that MCE could modulate the regulatory mechanism of NO,
cytokines and PGE2 in the LPS-activated Raw264.7 cells.
MCE inhibited the level of NO, PGE2, TNF-a, IL-1b and IL-6,
and the expression of iNOS and COX-2 activated by LPS.
These inhibitory effects were mediated through the inhibition
of IkBa phosphorylation and NF-kB activation.
NO is a free radical produced from l-arginine by nitric
oxide synthases (NOSs), and an important cellular second
messenger (28). The modulation of iNOS-mediated NO
release is one of the major contributing factors during the
inflammatory process (18). At adequate concentrations, NO
can generate or modify intracellular signals, thereby affecting
the function of immune cells, as well as tumor cells and
resident cells of different tissues and organs. However, its
uncontrolled release can cause inflammatory destruction of
target tissue during an infection (29–31). Moutan Cortex has
cytoprotective effects against NO-mediated neuronal cell
death in cultured cerebellar granule cells (CGCs) (32). In our
Figure 3. Reduction of LPS-activated iNOS and COX-2 expression by MCE.
The level of iNOSand COX-2 was monitored 12 h after treating cells with LPS
(1 mgm l
 1) with or without MCE pretreatment (i.e. 1 h before the LPS
treatment). The amount of protein loaded in each lane was confirmed by actin
protein expression.
(A)
(B)
Figure 4. Inhibition of LPS-activated p-IkBa protein expression and NF-kB
activation by MCE. The level of the p-IkBa protein (A) was monitored for
15 min after treating the cells with LPS (1 mgm l
 1) with or without the MCE
pretreatment (i.e. 1 h before LPS treatment). NF-kB activation (B) from the
nuclear extracts was analyzed by gel shift assay. Each lane contained 5 mgo f
the nuclear extracts. The results were confirmed by repeated analyses.
eCAM 2007;4(3) 331study, MCE reduced the level of iNOS expression in a
concentration-dependent manner.
PGE2 is generated by the sequential metabolism of
arachidonic acid by cyclooxygenase and it is associated with
inflammation (26). Cyclooxygenase exists in two isoforms;
COX-1 and COX-2. COX-1 is a constitutively expressed
enzyme with general housekeeping function. COX-2 is an
inducible isoform of cyclooxygenase (33,34), and its most
important role is in inflammation. Herb medicine containing
Moutan Cortex acts as a potent inhibitor of COX-1 and COX-
2 (35). Moutan Cortex also showed analgesic effect on the
PGF2a-induced allodynia in mice (36). We found that MCE
could suppress the induction of COX-2 by LPS, and
consequently reduce the production of PGE2 in a dose-
dependent manner.
NF-kB has been implicated in the expression of iNOS and
COX-2 protein. Activation of the NF-kB signaling cascade
results in the complete degradation of I-kB via phosphory-
lation and ubiquitination. Paeonol showed regulatory effects
on inflammatory cytokines-related anaphylactic reaction (37),
and cerebral disorder (38). Recently, paeonol was reported to
reduce TNF-a-stimulated iNOS proteinand mRNA expression
via inhibiting NF-kB activation (39). In this study, MCE
inhibited the phosphorylation of I-kBa and LPS-inducible
increase in the band intensityof NF-kB binding. Thus, it seems
that anti-inflammatory effect of MCE is partly responsible for
paeonol. To evaluate the anti-inflammatory activity of paeonol
in LPS-induced macrophage, studies on the effects of paeonol
on the mechanism of LPS-induced NO, cytokines and PGE2
are needed.
In conclusion, we determined that the MCE can have anti-
inflammatory activity by suppressing the phosphorylation of
I-kBa and the activation of NF-kB, and by inhibiting the
expression of iNOS and COX-2 in LPS-activated Raw264.7
cells.
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